Revenue growth masks 81% PAT collapse; quality deteriorating

Revenue +14.4% YoY, but consolidated PAT -81% YoY to ₹60 Cr (NPM 1.4%)

Confirmed: revenue up but EBITDA compressed—margin pressure evident

Driven by low-cost coal inventory benefit. Sustainable margin ~18%. Temporary.

From asset monetization (land & share sales), not organic. One-time benefit.

Consolidated PAT -81% YoY reveals overseas & associate drag; quality concern

Split basic chemistry into Living, Industrial, Farm Essentials. Aligns reporting with portfolio de-risking. Reflects strategic shift away from soda ash cyclicality—no numeric P&L impact yet, but capex skew evident.

Southeast Asia exports now at breakeven/unremunerative. Unless China rationalizes capacity, no recovery. Prior calls expected normalization; now explicit loss scenario.

Prior: 'broadly flat demand'. Now: 'challenging due to global oversupply from China, inventories at all-time high 1.73 Mt, pricing subdued'. China producers losing money at ₹160-170 USD FOB.

Sustainable India EBITDA margin ~18% (vs prior run-rate 22-24% implied). Q1 28% is inventory-benefit aberration, not maintainable.

Portfolio reshaping toward non-cyclical, sustainability-led products with higher customer stickiness and less pricing volatility. Capital allocation will reflect focus. No new synergy quantification.

Inventory gain will reverse as old low-cost coal clears and new inventory arrives at higher freight-adjusted prices. Sustainable margin ~18%. Spot price increases not yet fully transmitted to all contracts.

Export volumes to SE Asia unremunerative, likely remain so through FY27 unless China rationalizes capacity. Unlikely to see uplift. Domestic US stable but no volume growth.

HFO costs and oil prices hit; contracts hedged through October. Will attempt customer pass-through but constrained. After October, if war drags on, margin pressure continues.

UK had two one-offs: GBP 2.4M loss on EU ETS sale (cyclical) and prior-period adjustments. Expected EBITDA-positive and PBT breakeven by end of FY27, from next quarter onward as one-offs don't repeat.

Sold some land in Q1 and sold shares we were holding. Contributed to debt reduction but one-time benefit, not operational.

First battery pack made and testing. Strategy focused on static/stationary application for renewable storage and data centers, not mobility. Piloting phase will take better part of year. Full-scale plant 2+ years after commercialization. Soda ash use as cathode material is key linkage.

USD 160-170 likely the floor; most Chinese producers losing money on cash basis. Pricing holding steady vs Yuan parity. Company will work with regulators on anti-dumping in India market.

Different market dynamics; UK and Singapore sell to premium regulated markets requiring customer pre-approval. India sees competitive intensity from local competitor capacity, but not from China. No major shift in bicarb as of now.

Unit-by-unit impact. US: logistics only. UK: hedging gas, open item on revert-to-mean. Kenya: hedged through October, exposed thereafter. India: coal freight from Indonesia is key; limestone exposure beyond Oct/Nov if geopolitical tension continues. Biggest risk post-October.

Annualized capex around depreciation (~₹1,200 Cr). Will try to stay below. Non-core land will be monetized in H2 or after Q2. No quantified target but strategic approach to stay debt-neutral.

Initially understated. Confirmed ₹43 Cr reversal is one-off; normal run-rate higher than that. Q1 unusual: high bonus payouts, variable pays. Largely rupee depreciation on overseas payroll impact.

Management expects stabilization vs Q1 but acknowledges pricing pressure in soda ash will persist. Living/Farm segments supporting growth.

Q1 inflated by inventory gains and cost reversals. Freight cost headwind into Q2 will compress margin. Supply rationalization in China key to medium-term recovery.

Management committed to staying at or below depreciation. Skewed toward Living Essentials (salt, silica, prebiotics) and away from soda ash. Capex recovery post-2028.

HFO and freight costs spiked; Kenya hedged only through October. If conflict continues beyond Oct/Nov, limestone imports from Middle East become prohibitive, energy costs soar for India operations.

Chinese inventories at all-time 1.73 Mt; producers losing money on cash basis at USD 160-170 FOB. No significant capacity curtailments announced. Market rebalancing dependent on supply rationalization, not demand recovery. Pricing subdued through FY27.

SE Asia exports at breakeven/unremunerative. Domestic US stable but no volume growth. Logistics cost pass-through incomplete. US operations dragging consolidated EBITDA; export recovery unlikely absent China rationalization.

Consolidated PAT -81% YoY (₹60 Cr) vs standalone +12% reveals massive overseas drag (US, Kenya, UK) and IMACID (associate) not producing. Q1 PAT benefited from ₹43 Cr staff cost reversal and inventory gains; sustainability poor.

Net debt reduced ₹300 Cr in Q1 via land & share monetization. Not sustainable operationally. If geopolitical costs escalate and margins compress further, capex cuts or new asset sales may be needed; balance sheet flexibility limited.